Furthermore, cells with CDC25B transient knockdown showed slower cell growth compared with control siRNA transfected BT549 and HS578T breast cancer cells (Figure 1D), a process that was through the blocking of cell cycle progression (Figure 1E and Supplementary Figure S1A). Here, CDC25B is linked to breast cancer.